How to treat a venlafaxine (Effexor) XR overdose of 450mg that occurred over 24 hours ago?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Venlafaxine XR Overdose of 450mg at 24 Hours Post-Ingestion

For a venlafaxine XR overdose of 450mg that occurred over 24 hours ago, immediate hospital evaluation is necessary with cardiac monitoring, supportive care, and sodium bicarbonate administration if QRS prolongation or cardiac toxicity develops.

Initial Assessment and Monitoring

  • Cardiac monitoring: Venlafaxine is associated with QRS prolongation, QT interval prolongation, and potentially fatal cardiac arrhythmias 1, 2
  • Vital signs: Monitor for hypertension, tachycardia, and hypotension (which can occur later in severe cases)
  • Neurological assessment: Check for seizures, altered mental status, and signs of serotonin syndrome
  • ECG: Obtain immediately to assess for QRS widening, QT prolongation, and arrhythmias
  • Laboratory tests:
    • Complete blood count
    • Comprehensive metabolic panel (especially liver function)
    • Creatine kinase (to assess for rhabdomyolysis)

Treatment Approach

Immediate Interventions

  1. Supportive care: Ensure adequate airway, breathing, and circulation
  2. Cardiac toxicity management:
    • Sodium bicarbonate: Administer for QRS prolongation or cardiac toxicity 1
    • Initial dose: 1-2 mEq/kg IV bolus for adults
    • Target serum pH of 7.45-7.55

Specific Complications Management

  1. Seizures:

    • Administer benzodiazepines (first-line treatment) 1
    • Consider phenobarbital for refractory seizures
  2. Hypotension:

    • IV fluid resuscitation
    • Vasopressors if needed
  3. Serotonin syndrome:

    • Benzodiazepines for agitation and tremor
    • Supportive care
    • Consider cyproheptadine in severe cases

Monitoring Period

  • Continue cardiac monitoring for at least 24 hours after overdose
  • Observe for delayed toxicity, as venlafaxine XR has extended-release properties 1
  • Monitor for recurrent symptoms, especially with extended-release formulations

Clinical Considerations

Risk Assessment

  • Venlafaxine overdose carries higher mortality risk compared to SSRI antidepressants 2, 3
  • Fatal outcomes have been reported with venlafaxine overdoses 4, 5
  • 450mg is approximately 3 times the maximum daily dose, which may cause significant toxicity

Mechanism of Toxicity

  • Venlafaxine blocks sodium channels in cardiac tissue, similar to class I antiarrhythmic drugs 6, 7
  • This sodium channel blockade explains the QRS prolongation and ventricular arrhythmias seen in overdose
  • Serotonin and norepinephrine reuptake inhibition contributes to cardiovascular and neurological effects

Common Pitfalls to Avoid

  • Underestimating cardiac risk: Even at 450mg, venlafaxine can cause significant cardiac toxicity
  • Premature discharge: Extended monitoring is necessary due to the extended-release formulation
  • Missing signs of serotonin syndrome: Agitation, hyperreflexia, clonus, and hyperthermia require prompt recognition
  • Failure to treat QRS prolongation: Sodium bicarbonate should be administered promptly if QRS widening occurs

While 450mg is not as severe as the multi-gram ingestions reported in fatal cases 4, 5, the extended-release formulation and venlafaxine's cardiac toxicity profile warrant thorough evaluation and monitoring.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[A fatal overdose of venlafaxine].

Ugeskrift for laeger, 2014

Research

[Acute lethal poisoning with venlafaxine].

Przeglad lekarski, 2010

Research

Mechanism of sodium channel block by venlafaxine in guinea pig ventricular myocytes.

The Journal of pharmacology and experimental therapeutics, 1999

Research

A fatal case of venlafaxine overdose.

Journal of medical toxicology : official journal of the American College of Medical Toxicology, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.